Armstrong, Fleming & Moore, Inc Novo Nordisk A S Transaction History
Armstrong, Fleming & Moore, Inc
- $165 Billion
- Q4 2024
A detailed history of Armstrong, Fleming & Moore, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Armstrong, Fleming & Moore, Inc holds 5,924 shares of NVO stock, worth $449,572. This represents 0.31% of its overall portfolio holdings.
Number of Shares
5,924
Previous 7,532
21.35%
Holding current value
$449,572
Previous $897 Million
43.18%
% of portfolio
0.31%
Previous 0.52%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,885Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.51 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.18 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$986 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$959 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$926 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $171B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...